2012/01/21

Modification of cysteine residue in p65 subunit of nuclear factor-kappaB (NF-kappaB) by picroliv suppresses NF-kappaB-regulated gene products and potentiates apoptosis.


Cancer Res. 2008 Nov 1;68(21):8861-70.

Modification of cysteine residue in p65 subunit of nuclear factor-kappaB (NF-kappaB) by picroliv suppresses NF-kappaB-regulated gene products and potentiates apoptosis.

Source

Department of Experimental Therapeutics, Cytokine Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.







Blood. 2009 Feb 26;113(9):2003-13. Epub 2008 Oct 24.

Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumolleads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis inleukemia cells.

Source

Cytokine Research Laboratory, Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA



Figure 4D - p65C38S +/- Picroliv. Right 2 lanes are cloned.



0 件のコメント:

コメントを投稿